This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Varicella-zoster virus (VZV) / HHV-3 gE / glycoprotein E (Catalog# 40907-V08H; Q9J3M8; Met1-Tyr538). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.